Technical analysis of Lifecore Biomedical, Inc. (LFCR): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities.
Price Performance
| 1 month | -5.02% |
| 3 months | -24.91% |
| Year-to-date | -49.14% |
| 1 year | -45.97% |
| 3 years | -49.02% |
| 5 years | -59.18% |
52-Week Range
| 52-week High | $8.98 |
| 52-week Low | $3.63 |
| Avg Volume (90d) | 177K |
Technical Indicators
| SMA 50 | $4.52 |
| SMA 200 | $5.81 |
| Beta | 0.88 |
| 30-day Volatility (annualised) | 57.2% |
| Price vs SMA 50 | -7.9% |
| Price vs SMA 200 | -28.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $7.19 | |
| 2025-11 | $7.90 | +9.9% |
| 2025-12 | $8.18 | +3.5% |
| 2026-01 | $8.69 | +6.2% |
| 2026-02 | $7.20 | -17.1% |
| 2026-03 | $3.72 | -48.3% |
| 2026-04 | $5.07 | +36.3% |
| 2026-05 | $5.02 | -1.0% |
| 2026-06 | $5.25 | +4.6% |
| 2026-07 | $4.42 | -15.8% |
| 2026-08 | $4.46 | +0.9% |
| 2026-09 | $4.16 | -6.7% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | $-0.08 | $66M |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
Price
| Price | $4.16 |
| Market Cap | $156M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 9.74 |
| EV / EBITDA | -73.17 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 9.64 |
| Current Ratio | 3.87 |